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Abstract The methods boron measurement in BNCT system has generally progressed with developments in analytical 
instrumentation. Spectrophotometric methods remained the methods of choice for most routine applications until the 
development of ICP-OES. ICP-OES was also not adequately sensitive for nutritional and medical research involving 
animal tissues that are naturally low in boron (B). The development of plasma-source MS (e.g., ICP-MS) not only has 
overcome most of these drawbacks, but also its capability of measuring B isotopes. The application of nuclear reaction 
methods (mainly prompt-γ spectrometry) has remained limited to some specialized fields. The validity and 
comparability of three different analytical techniques (QNCR, PGAA, and ICP-MS) for boron measurement in 
biological samples and application of these methods for examination of blood and tissue samples from a clinical study 
on boron uptake in blood, tissue, and neoplastic tissue, after infusion of BPA. The PET-based approach to TPS has been 
applied in BDTPS and a preliminary evaluation of the correct operation has been performed using a heterogeneous 
boron phantom, called HEBOM. The validation has been accompanied by calculations done with SERA, following the 
standard approach. BDTPS needs further in vivo experimental validations.  
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INTRODUCTION 
Boron plays also a role in life sciences, 
though its biological and physiological 
potential has not been fully explored yet. For 
example, in animal models, boron was found 
to ameliorate fulminant hepatic failure by 
counteracting the changes associated with the 
oxidative stress. In cancer therapy, boron is 
mostly associated with BNCT, though more 
recently, the use of polyhedral boron 
compounds was proposed as carriers for 
radionuclide therapy and diagnostics Sommer 
AL, Lipman CB Bregadze VI,et al.  
Polyhedral heteroboranes have been the 
subject of intense research for over 40 years. 
A subset of this extensive class of compounds 
are dicarba-closo-dodecaboranes, commonly 
referred to as carboranes (an abbreviation of 
the IPUAC name carbaboranes) having the 
general formula C2B10H12. 
Radiopharmaceuticals were assessed by M.F. 
Hawthorne, A. Maderna, polymers were 
assessed by D.K. McLemore, et al, and a 
assortment of unique coordination compounds 
were assessed by M. Westerhausen, et al. The 
initial attraction to carboranes for medicinal 
chemistry research was a result of their high 
boron content and stability to catabolism, which 
are important criteria for BNCT agentts. Boron 
is also used as a source of short range α (alpha) 
particles in cancer treatment using Boron 
Neutron Capture Therapy (BNCT) were 
assessed by Raaijmakers, C. P, et al. 
BNCT is a novel technique for the 
treatment of cancer that uses 10B-labeled 
compounds and neutron radiation to kill 
cancerous cells. The significance of B 
compounds in BNCT sistems from high neutron 
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cross section or capture probability (3838 
barns) of the 10B atom compared to other 
biologically ubiquitous atoms such as carbon 
(0.003 barns), hydrogen (0.33 barns), nitrogen 
(1.8 barns) and oxygen (0.0002 barns) atoms. 
The short range (10 µm) cytotoxic α (alpha) 
radiation released in the neutron capture 
reaction kills the targeted cancerous cells 
without affecting the neighboring healthy 
cells were assessed by Moore, D. E. The most 
important requirements for a BNCT delivery 
agent are: 1.) low toxicity and normal tissue 
uptake, with a tumor:normal tissue and 
tumor:blood (T:Bl) boron concentration ratios 
of ~3; 2.) tumor boron concentration of 
~20 μg 10B/g tumor; 3.) relatively rapid 
clearance from blood and normal tissues, and 
persistence in tumor during neutron 
irradiations. The only two BNCT delivery 
agents currently used in clinical trials are 
sodium mercaptoundecahydro-closo-
dodecaborate (Na2B12H11SH), commonly 
known as sodium borocaptate (BSH), and the 
boron-containing amino acid (L)-4-
dihydroxy-borylphenylalanine, known as 
boronophenylalanine or BPA. Neither of 
these agents adequately fulfills the criteria 
indicated above, for this reason third 
generation agents incorporating one or more 
polyhedral borane anions or carboranes was 
proposed as carriers for radionuclide therapy 
and diagnostics in cancer therapy associated 
with BNCT. 
Precise measurement of B and its 
isotopes is necessary for the evaluation of the 
tumor specificity and pharmacokinetics of B 
compounds for BNCT. Often it is necessary 
to be able to measure B in very small samples 
(e.g., biopsy-needle samples) to make sure 
that the drugs are actually localized in target 
tissue before exposing the patient to neutron 
sources were assessed by Johnson, D. A, et al. 
Therefore, accurate measurement of the B 
concentration is very critical for these 
applications. The National Institute of Standard 
and Technology (NIST) certified Standard 
Reference Materials (SRMs) such as NIST-boric 
acid standard for B isotope ratio and NIST-
botanical standards for total B concentrations are 
widely used for verifying the accuracy of a 
measurement. A small amount of siliceous or a 
calcareous mineral matter present in these SRMs 
may contribute to the errors that may not be 
resolved by analytical methods. Therefore, one 
must use caution to ensure that the heterogeneity 
found in SRMs is appropriately considered and 
dealt with were assessed by Lindstrom, R.M, et 
al. The purpose of this study is to assessment of 
analytical instrumentation for boron 
measurement in BNCT system. 
DISCUSSION 
Spectrophotometric Methods 
Plasma-Source Methods 
Introduction of plasmas as ionization 
sources and the development of plasma-source 
analytical instruments (plasma-source-OES and 
MS) provided higher sensitivity and lower 
detection capability for B measurement than was 
possible by spectrophotometric, flame 
AES/AAS, and time consuming nuclear 
methods. There are several types of plasma, 
namely, the direct current (DCP) were assessed 
by Urasa, I. T, the inductively coupled plasma 
(ICP) were assessed by Kempster, P. L, et al, the 
microwave induced plasma (MIP) were assessed 
by Evans, E. H, et al and the glow discharge 
plasma (GDP) were assessed by Sheppard, B. S, 
et al. Plasmas have been generated from a 
number of gases or their mixtures were assessed 
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by Jarvis, K. E. et al; however, most 
commercial plasma-source instruments use an 
argon ICP (i.e., ICP generated from argon) 
for ionization. The plasma source instruments 
are of two kinds, based on the detection 
method they employ (a) plasma source optical 
emission spectrometry (OES) such as ICP-
OES and DCP-OES and (b) plasma-source 
mass spectrometry (MS) such as ICP-MS, 
DCP-MS, and microwave induced plasma 
(MIP)-MS. OES has also been called atomic 
emission spectrometry (AES).   
Atomic spectrometric methods such as 
AES and AAS revolutionized the 
measurement of a large number of elements, 
but these methods were not very sensitive for 
the element B. As a result, 
spectrophotometric methods remained the 
methods of choice for most routine 
applications until the development of ICP-
OES. ICP-OES was also not adequately 
sensitive for nutritional and medical research 
involving animal tissues that are naturally low 
in B. Development of plasma-source MS 
(e.g., ICP-MS) not only has overcome most 
of these drawbacks, but also its capability of 
measuring B isotopes has made possible (1) B 
concentration measurement by isotope 
dilution, (2) verification of B concentration 
by isotope fingerprinting in routine analysis, 
and (3) measurement of total B concentration 
and B isotope ratio in the same run for 
biological tracer studies. Therefore, plasma 
source MS appears to be the method of choice 
among present-day technologies. 
ICP-MS 
The ICP-MS is often the method of 
choice over ICP-OES and spectrophotometric 
methods for B measurement. The advantages 
of ICP-MS over other methods are higher 
sensitivity, lower detection limits, and 
simultaneous measurement of 10B to 11B isotopic 
ratio and total B concentration in a sample. The 
ability of ICP-MS to measure B-isotope ratios 
renders this instrument especially suitable for 
biological B tracer studies. The reported 
detection limits are at the ppb level, e.g., one 
ppb to 3 ppb  in biological materials, 0.15 ppb in 
saline waters were assessed by Gregoire, D. C, 
and 0.5 ppb in human serum were assessed by 
Vanhoe, H,et al. The uniqueness of ICP-MS is 
also due to its capability to carry out B 
measurement by the isotope dilution method 
which is considered the most precise for 
quantitative measurement. 
The external calibration with an internal 
standard is most widely used method for plasma-
source OES and MS because of its simplicity 
and labor efficiency. Other methods, such as 
standard addition, addition calibration, and 
isotope dilution methods are less common and 
are generally employed to deal with difficult 
sample matrices or to improve precision. For the 
external calibration method, an internal standard 
as close as possible to the mass number of the 
determinand elements should be selected were 
assessed by Vanhaecke, F,et al. Beryllium is the 
closest in mass number to B and therefore it is 
the most commonly used internal standard for B 
measurement. Use of Be as an internal standard 
was effective in mitigating matrix interferences 
were assessed by Evans, S.; Krahenbuhl, U  and 
corrected the matrix induced suppression of 10B 
signals (85.6 ± 5.2% recovery relative to 0.14% 
HNO3), yielding 99.6 ± 2.5% relative signal 
intensities were assessed by Vanhoe, H.; Dams, 
R.   
The development a model to estimate the 
10B concentration value from the counts 
associated to each voxel by the PET 
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tomographer. The 18F-BPA is infused into the 
patient, who later undergoes scanning. The 
PET scanner can detect the radiation emitted 
when a positron-electron annihilation reaction 
occurs and ascertains the location of this 
reaction.  
The synthesis of the 18F-BPA has 
induced several scientists to put their 
attention on a Positron Emission Tomography 
(PET) based on BNCT.  In particular, at the 
Kyoto Prefectural University of Medicine 
were assessed by Imahori Y, et al (Japan) and 
contemporarily at the Departments of 
Radiobiology and Neurosurgery were 
assessed by Kabalka G W,et al, University of 
Tennessee Medical Centre (USA) two groups 
of scientists have independently labelled 
boronophenylalanine (BPA) with 18F atom (a 
positron emitter). 
For an example picture related ICP-OES 
or ICP-MS and FBPA-PET see Figure 1. 
 
Figure 1. Measurement and Prediction of Boron 
Concentration 
Spectral overlap of the 12C peak on the 
11B peak may interfere in 11B/10B ratio 
measurement if the sample solutions or the 
digest contains high levels of organic carbon 
as commonly found in microwave digests of 
biological materials. Evans and Krahenbuhl 
noted a significant interference of 12C on B in 
the microwave digests of biological materials 
when the measurement was made in the normal 
resolution mode (0.8 µ). In the high resolution 
mode (0.6 µ) the effects depended on the sample 
types: the 11B peak of the hay sample was 
resolved completely, but those for the kidney 
and the flour sample were resolved only 75 and 
55%, respectively. An analyst should always 
watch for the possibility of error in B isotope 
ratio measurement due to anticipated 
enhancement in 11B signals by 12C. Where the 
isotope ratio measurement is not required, total 
B can be computed on the basis of 10B to avoid 
the error due to the overlap of 12C-peak. Spark 
source mass spectrometry (SSMS) is mainly 
used to determine concentrations of trace 
elements. Lukaszew et al. noted a satisfactory 
performance of SSMS for the measurement of 
isotopic composition. Secondary ion mass 
spectrometry (SIMS) employs sputtering of the 
surface atoms from small areas (typically, 250 x 
25 µm) of the sample by an energetic primary 
ion beam were assessed by Jones, L. E.; 
Thrower, P. A. The secondary ions generated 
from the sample are detected in a mass analyzer.  
The applications of SIMS to BNCT were 
assessed by Moore. While SIMS can be used for 
quantitative B measurements in small samples 
also, it is particularly suitable for the 
measurement of intracellular B concentrations in 
BNCT. A very powerful tool for subcellular 
boron imaging is secondary ion mass 
spectrometry (SIMS). SIMS pictures image the 
boron distribution with a resolution of several 
nanometres, thus enabling the analyst to assess, 
whether the boron is found inside the cell 
nucleus, in the cytoplasm or in extracellular 
spaces were assessed by Smith DR, et al.  For an 
example picture related SIMS see Figure 2 A 
and B. 
Indonesian Journal of Physics and Nuclear Application, Vol. 2, No. 1, February 2017 
24 
 
 
Figure 2.  A. Devices of Secondary ion Spectrometry (SIMS) and B. Image SIMS
Nuclear Reaction Analytical Methods 
Neutron Activation Analysis 
In general, the sample is bombarded 
with neutrons, the elements of interest are 
made radioactive and quantity of the element 
is determined by measuring the radioactivity 
or radioactive decay products. NAA is a 
nondestructive method capable of handling 
solid samples with multi element detection 
capability and generally low detection limits.  
However, it is not suitable for sample mass or 
liquid volumes that pose a threat of 
radioactive leaks after activation. Ward et al. 
found good agreement between the value of 
18 elements determined by NAA and ICP-
MS. The nuclear methods for B measurement 
were recently assessed by Pillay and Peisach. 
The measurements by the NAA methods 
require access to a nuclear reactor for the 
production of thermal neutrons for 
bombardment to convert isotope(s) of interest 
in a sample to radioisotopes were assessed by 
Johnson, P. E. Boron is an exception to this 
strategy. The activation of 10B by an incident 
beam of thermal neutrons does not make it 
radioactive but causes the following neutron-
capture reaction: 
 
This reaction involves only the 10B isotope, 
which has approximately 20% abundance in 
naturally occurring B. All NAA methods for B 
measurement are based on the measurement of 
one or more products (α-particles and γ-photons) 
of this reaction. Perhaps the most important 
method based on the measurement of α (alpha) 
particles is neutron activation (NA) MS while 
that based on the measurement of gama rays is 
prompt γ-ray spectrometry. 
Methods based on α particles 
Two methods detecting the fragments of 
the 10B(n,α)7Li reaction are neutron  activation 
mass spectrometry (NA-MS) and quantitative 
neutron capture  radiography (QNCR) were 
assessed by Gabel D, et al. In NA-MS the He-
nuclei emitted after neutron capture are detected 
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directly by a mass spectrometer. 
Measurements may be carried out with very 
low quantification limits, however, there may 
be a considerable contribution to the 
background signal by other isotopes emitting 
α- particles after neutron capture. QNCR is a 
quantitative application of neutron capture 
radiography (NCR), which is used for the 
qualitative analysis of materials which emit 
charged particles upon neutron capture. For an 
example picture related NCR see Figure 3. A. B. 
 
Figure 3. A. Devices of Neutron radiographic metthods and B.  Alpha-and proton tracks of a radiographic image 
processing.  The arrows all point to alpha tracks:  there are examples given for track growth for δ=900 (black) and 
δ≠900 (red and green; with δ (green) > δ 9red).  The image is scaled 48 x 36 Qm2 
The protocol for neutron capture 
radiography in BNCT usually includes 
fixation of a piece of tissue on a SSNTD film, 
as the major objective of radiographic 
analysis is to image the boron distribution, 
therefore, any space left (or any “obstacle”) 
between detector and sample would lead to a 
distorted picture. All radiographic images for 
the work presented were produced using a 
polyallyldiglycol-carbonate film purchased 
from TASTRAK (Track Analysis Systems 
Ltd., Bristol, United Kingdom). TASTRAK 
films are sensitive only towards irradiation of 
charged particle energies and fast neutrons.     
For application of neutron radiography 
to analyse the boron content in tissue 
samples, tracks are almost exclusively 
produced by protons, 4He- and 7Li nuclei. 
Though the image for analysis is created by 
chemical etching, the actual evaluation of the 
data especially for quantitative analysis has to 
take place using a microscope and special 
imaging software. Contrary to NA-MS, analysis 
with QNCR is carried out using solid state 
nuclear track detectors (SSNTDs) enabling the 
user to spatially analyse the boron concentration 
in a sample by visualisation of tracks created by 
the impact of 4He and 7Li onto the STNTD’s 
surface. Closely related to QNCR is spatially 
selective α-spectrometry, using a different 
detector system.    
Neutron activation mass spectrometry (NA-
MS): Iyengar et al. and Clarke et al. described an 
NA-MS method for simultaneous measurement 
of lithium and B in biological materials. The 
sample was placed in an ultrapure polyethylene 
‘‘liner’’ and freeze-dried. The liners containing 
the freezedried samples were placed in lead 
containers and evacuated to about 1005 Pa. The 
lead containers were pinched-sealed following 
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evacuation for neutron irradiation. A static 
mass spectrometer was used to measure 4He 
(from 10B) and 3He (from 6Li) generated by 
the NA reaction. The error rate at ≥ 1 ppm B 
concentration was 1–5% but at 6 ppb B the 
error rate increased to 75%. This sensitivity is 
not adequate for BNCT and some nutritional 
and environmental applications. 
Methods based on the measurements of γ-
rays 
The most obvious advantage of such 
techniques over other techniques is that they 
are non-destructive. Several of these 
techniques are based on the on the high 
probability of 10B for neutron capture 
reactions, as the isotope has a cross section 
for thermal neutron of 3837 barn. The 
10B(n,α)7Li reaction provides the possibility 
to detect two different kinds of fission 
products. Prompt-gamma activation analysis 
(PGAA, also PGNAA, PGRA or PGRS) is a 
form of gamma spectroscopy, which detects 
gamma rays emitted by short-live isotopes 
created by neutron capture. Neutron 
activation of the 10B istotope to 11B* is followed 
by fragmentation of the latter and by emission of 
a 478 keV gamma photon in 94 % of neutron 
capture reactions by the 7Li-nucleus. The 
spectroscopic recording of the gamma spectrum 
provides an indirect method to measure the 
integral boron content in a sample were assessed 
by Riley KJ, Harling OK.    
Prompt γ spectroscopy is an extensively 
used method for the measurement of 10B were 
assessed by Riley KJ, Harling OK. The γ-ray 
emitted from the disintegrating 10B nuclei due to 
the action of the neutron is detected. This is also 
a nondestructive method; however, it is not 
sensitive for the detection of low B levels 
(generally, < 5 µg g-1) in the sample. As B 
concentration in the sample decreased, counting 
time to achieve desired precision increases 
logarithmically were assessed by Rogus, R, et al.  
For example, counting time necessary to achieve 
1% precision was 10 h for a sample containing 
one ppm B and 50 h for a sample containing 0.5 
ppm B. For an example picture related PGAA 
see Figure 4 A and B. 
 
Figure 4.  A. The PGAA facility at FRM II Munich and  B.  Promp Gamma Activation Analysis 
For tumour samples, only QNCR was 
chosen, as it was the only method capable of 
performing locally selective boron 
measurement. For blood samples, first analysis 
by PGAA was performed, after which the same 
samples were used for subsequent analysis by 
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ICP-MS. The only samples which were 
measured by all three methods were the 
biopsies from tumour free tissue.  
First, cryosections for QNCR were 
prepared from the original piece of tissue 
taken after surgery. The remainder of the 
piece was then sent to Petten and Munich and 
measured by PGAA. After that, these samples 
were analysed by ICP-MS. For an example 
picture of the boron comparison of tissue 
samples using QNCR, PGAA and ICP MS see 
Figure 5. 
 
Figure 5.  Comparison of tissue samples 
The usual approach to validate analytical 
methods in direct comparison is to carry out 
measurements with all of the methods of a 
suitable standard reference material. One or 
several standard reference materials are 
measured by one or several analytical 
methods by a number of laboratories. The 
values have then to be collected and evaluated 
statistically to determine the conformity of 
each method against the others. Ideally, only 
the person collecting the data from each 
laboratory knows the content of the analyte to 
ensure the quality of such a trial. Such trials 
eventually yield individual information about 
the analytical quality of each participating 
laboratory, but they may also reveal, if there 
is a systematic error in boron measurement by 
one specific method (provided that such 
errors can be surely traced back to the method 
alone and not to sample preparation, the analyst, 
or the laboratory). To ensure the correctness 
(and, thus, their relevance for future research) of 
the data gathered from the samples taken during 
the clinical study, it was decided that the 
analytical methods used in this work had to be 
validated. 
For the analytical methods chosen, there 
was no suitable standard reference material 
commercially available. This was particularly 
difficult, since QNCR allows only the 
measurement of solid samples, whereas ICP-MS 
can only process liquid or liquefied samples. 
Also, not only the mere boron measurement, but 
especially the boron measurement in a tissue 
matrix (all three methods) or blood matrix (ICP-
MS and PGAA) had to be carried out correctly. 
Indonesian Journal of Physics and Nuclear Application, Vol. 2, No. 1, February 2017 
28 
 
It was therefore decided to prepare an 
individual standard reference material for 
QNCR, which would later be measured by 
ICP-MS and QNCR. 
After that, all samples from the clinical 
study would then be measured with the 
matching analytical method. Eventually for 
calibration of QNCR, standard reference 
samples of BPA in whole blood were 
prepared. The known boron concentration in 
these samples was measured by ICP-MS and 
PGAA to check both methods. In Figure 6 a 
schematic is shown illustrating the 
connections between measurements and 
samples, as well as the blood reference 
samples. Unfortunately, it was not possible to 
perform the sequence of analysis for all 
samples of tumour free tissue. Several 
biopsies were used up completely for 
preparation of the cryosections. Therefore, in 
order to increase statistics for the 
measurements with PGAA and ICP-MS, the 
smallest samples were used for PGAA 
analysis first. Since they had to be measured 
at room temperature, thawing made these 
samples completely ineligible for analysis by 
QNCR, so only analysis by ICP-MS was 
performed afterwards. 
Figure 6. Connection between QNCR, PGAA and 
ICP-MS as methods for boron measurement, the   
samples obtained during the clinical study and blood 
reference samples used for calibration during analysis with 
QNCR.  Blue arrows indicate measurement of samples by 
a specific method, the green arrow indicate that one set of 
samples was used for production of reference samples for 
QNCR. 
Boron Imaging 
Positron Emission Tomography (PET) is a 
functional imaging technique that allows the in 
vivo investigation of metabolic processes. This 
is made possible by linking a positron-emitting 
nucleus to the molecule of the substance 
(labelling) whose biological kinetics must be 
investigated.   
These studies showed that the 10B, used in 
BNCT, diffuses heterogeneously throughout the 
whole brain, without a clear distinction between 
tumour and healthy tissue. This consideration 
leads to a PET-based approach, that differs from 
the actual protocol based on the hypothesis of 
uniform two-zones boron distribution. In these 
studies important parameters for treatment 
planning have been achieved, such as the 
optimisation of the treatment time, the 
optimisation of the infusion protocol and the 
measurement of the cellular-level distribution of 
boron. Consequently, the idea to couple the 
treatment planning system with the boron 
distribution data acquired through PET scanning 
has been circulating in the BNCT scientific 
community. In particular, the BNCT Group at 
DIMNP of Pisa University (Italy) has 
collaborated with the Joint Research Centre 
(JRC) of Petten (The Netherlands) in order to 
design and implement this different approach to 
the TPS (Treatment Planning System). The idea 
was to link the PET data, related to the in vivo 
boron distribution, to the 3D modelling to make 
a realistic Monte Carlo (MC) simulation. 
This idea led to the development of the 
original prototype software CARONTE were 
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assessed by Cerullo N, et al. This code 
contained a pre-processing module that 
received in input the PET images and 
prepared the input file for the MC simulation. 
Then a post-processing module provided 
some simple visualization tools for the 
analysis of the results. CARONTE was 
employed to carry out a comparative study 
between the standard and the PET based 
approach were assessed by Cerullo N, 
Daquino G G. However CARONTE built a 
simplified geometrical model of the patient’s 
head for the MC simulation (a Snyder 
phantom, widely used in this field since early 
NCT TPS studies), in which the appropriate 
boron concentration value was computed at 
the location of each voxel. A natural follow 
up of the CARONTE experience was the 
improvement of the PET-based TPS 
methodology and the development of a real 
TPS, which contains both the standard tools 
and the connection to the boron data acquired 
through the PET scanning. The new TPS is 
called Boron Distribution Treatment Planning 
System (BDTPS) were assessed by Cerullo N, 
Daquino G G, Muzi L and is written in Visual 
C++.  
The standard approach in the TPS 
foresees the definition of the tumour and the 
healthy tissue regions on the CT or MRI 
images. A Monte Carlo model is 
automatically set up in order to perform the 
simulation of the treatment. At the moment, 
there are several TPS’s in use in BNCT. Most 
of them make use of a Monte Carlo engine for 
the simulation of the nuclear reactions during 
the irradiation. For example, NCTPlan uses 
MCNP, SERA has rtt_MC in the background. 
The default BDTPS calculations are 
referred to the main doses and fluences to 
take into account in BNCT: 
• neutron fluence (thermal, epithermal, fast and 
total), 
• photon fluence; 
• boron dose; 
• hydrogen neutron capture dose (or gamma 
dose); 
• proton recoil dose; 
• nitrogen dose 
Figure 7.  Shows the main components of 
the PET-based approach to TPS (BDTPS). 
 
Figure 7. Main Components of PET-based Approach to 
TPS (BDTPS). 
For an example picture  related PET, MRI  
see Figure 8, 9 A and B. 
Figure 8. Clinical application of PET (BPA) 
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Figure 9. A. [18F] F-BPA-PET in severe form of NF-2 
and B.  Novel target for BNCT 
A preliminary validation of the 
methodology has been performed were 
assessed by Daquino G G, et al using a 
special phantom HEBOM able to reproduce 
as much as possible the heterogeneous boron 
distribution. In this way, the validation 
exercise can be considered as close as 
possible to the real situation, which appears 
from the PET scanning. HEBOM’s final 
design allows up to 64 vials to be placed in 
four layers, containing 8 different boron 
concentrations. Each vial has different colour 
depending on its boron content. The decision 
to colour the vials has been taken in order to 
facilitate quick vial recognition during the 
PET loading phase. The vials are located in 
the centre of the phantom. All the slabs 
contain clearance holes (15 mm diameter), 
between the vials, to host neutron and gamma 
detectors. Figure 10 shows HEBOM 
demounted (a) and mounted (b). 
 
Figure 10. HEBON demounted (a) and (b) infront the 
HB11 aperture. 
To provide the information necessary to 
reconstruct the 3D and the boron model in 
BDTPS, HEBOM had to be scanned with a CT 
and a PET tomographer. 
CONCLUSIONS 
The methods boron measurement in BNCT 
system has generally progressed with 
developments in analytical instrumentation. As a 
result, spectrophotometric methods remained the 
methods of choice for most routine applications 
until the development of ICP-OES. ICP-OES 
was also not adequately sensitive for nutritional 
and medical research involving animal tissues 
that are naturally low in B. Development of 
plasma-source MS (e.g., ICP-MS) not only has 
overcome most of these drawbacks, but also its 
capability of measuring B isotopes has made 
possible (1) B concentration measurement by 
isotope dilution, (2) verification of B 
concentration by isotope fingerprinting in 
routine analysis, and (3) measurement of total B 
concentration and B isotope ratio in the same run 
for biological tracer studies. Therefore, plasma 
source MS appears to be the method of choice 
among present-day technologies. 
The application of nuclear reaction 
methods (mainly prompt-γ spectrometry) has 
remained limited to some specialized fields. The 
validity and comparability of three different 
analytical techniques (QNCR, PGAA, and ICP-
MS) for boron measurement in biological 
samples and application of these methods for 
examination of blood and tissue samples from a 
clinical study on boron uptake in blood, tissue, 
and neoplastic tissue, after infusion of BPA. 
Compare a locally selective method (QNCR) 
with two integral measuring methods (PGAA 
and ICP-MS) to yield results in good agreement 
for the same tissue samples containing boron of 
a confirmed morphology. 
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The ongoing clinical study, a 
combination of computed QNCR with 
histological analysis was established as a 
suitable method to correlate the morphology 
of tissue and the boron concentration. The 
bulk sample analysis is not suitable to 
determine and to image the 10B concentration 
in tumour tissue, especially if characterisation 
of the uptake behaviour of BPA for future 
clinical application of BNCT is required. 
The PET-based approach to TPS has 
been applied in BDTPS and a preliminary 
evaluation of the correct operation has been 
performed using a heterogeneous boron 
phantom, called HEBOM. The validation has 
been accompanied by calculations done with 
SERA, following the standard approach. 
BDTPS needs further in vivo experimental 
validations. The modelling will be performed 
with both BDTPS and SERA. This suggests 
that the possibility to use more realistic boron 
distribution maps acquired by means of PET 
imaging in BNCT treatment planning 
deserves more consideration and further 
investigation. 
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